Pulmolan tablet contains ambroxol: it thins sticky phlegm and makes coughing easier. A convenient form for adults.
International name
ambroxol hydrochloride
Clinical-pharmacological group
Pulmonology → mucolytic and antitussive agents → mucolytic and expectorant agents
Composition
Active substance: ambroxol hydrochloride;
1 tablet contains 30 mg of ambroxol hydrochloride;
Excipients: lactose, copovidone, Aerosil, calcium stearate, crospovidone.
Dosage form
Tablets
Pharmacological properties
Ambroxol hydrochloride is a synthetic secretolytic and secretomotor preparation. It stimulates mucus formation in the bronchi, helps thin it and improves its discharge by increasing the activity of the ciliated epithelium. Ambroxol increases the concentration of surfactant in the lungs and helps prevent its destruction. It has a minor antitussive effect. Ambroxol has an anti-inflammatory effect, has antioxidant properties and stimulates local immunity.
Indications
Acute and chronic diseases of the respiratory tract accompanied by difficult elimination of viscous secretion (acute and chronic bronchitis, bronchiectatic disease, tracheitis, laryngitis, pharyngitis). Bronchial asthma with difficult sputum discharge, pneumonia, cystic fibrosis of the lungs; prevention and treatment of complications after lung surgery. Used for preparation for bronchoscopy and after the examination has been performed.
Contraindications
First trimester of pregnancy, peptic ulcer disease of the stomach and duodenum, hypersensitivity (allergy) to ambroxol or to another component of the drug.
Precautions for use
Consultation with a doctor is necessary before starting treatment.
The drug must not be used for longer than the established period without consulting a doctor.
In the second and third trimesters of pregnancy, consultation with a doctor is necessary before using ambroxol hydrochloride.
If the signs of the disease do not begin to disappear, or on the contrary the state of health worsens or undesirable reactions develop, treatment with ambroxol hydrochloride must be stopped and a doctor consulted about further use of this drug.
Interaction with other medicinal products
If the patient is taking other medicines, they must consult a doctor about the possibility of using this drug. Ambroxol hydrochloride increases the therapeutic effectiveness of doxycycline, cefuroxime and amoxicillin. The drug causes an increase in the concentration of rifampicin in the lungs. This drug may be used together with cardiac glycosides and diuretics; a combination of ambroxol hydrochloride with theophylline is therapeutically appropriate. Simultaneous use of ambroxol hydrochloride with antitussive drugs that inhibit the discharge of sputum is not recommended.
Special instructions
Consultation with a doctor is necessary before and during treatment. The drug is secreted together with breast milk, however the use of ambroxol hydrochloride in therapeutic doses does not cause side effects in infants.
Method of use and doses
Adults and children over 12 years take 1 tablet 2 times a day, and when necessary, 3 times a day. In exacerbations of chronic diseases, the single dose may be increased to 60 mg (2 tablets) 2 times a day. Children from 5 to 12 years are usually prescribed 15 mg (1/2 tablet) 2-3 times a day, and children from 2 to 5 years 7.5 mg (1/4 tablet) 2-3 times a day. The drug is taken during or after a meal with a small amount of water. The therapeutic dose in children is 1.2-1.6 mg/kg 2-3 times a day. The course of treatment is 4-14 days.
Symptoms of overdose: cases of overdose have not been described, however digestive disturbance, discomfort or pain in the epigastric region, a feeling of stomach fullness, nausea and vomiting are possible. In other cases of overdose, the use of the drug must be stopped and a doctor consulted. Therapy is symptomatic.
